Services

Chemotherapy

Chemotherapy is the most common medical treatment for cancer. Chemotherapy can be either injections or tablets. Chemotherapy kills rapidly dividing cells (cancer cells). Chemotherapy can be used to shrink cancers before surgery or after surgery to reduce the risk of recurrence. The temporary side effects of chemotherapy include nausea, vomiting, hair loss, oral ulcers and low blood counts.

Immunotherapy or Biological Therapy

Immunotherapy is the latest medical treatment for cancer. These drugs work by stimulating our immune system (T cells) to recognise and eliminate cancer. As compared to chemotherapy, immunotherapy has lesser side effects. Less frequently, patients can develop autoimmune side effects due to immunotherapy. Unfortunately, most patients cannot afford immunotherapy due to the prohibitive cost.

Hormonal Therapy

Hormonal therapy could be either tablets or injections. Patients with breast cancer, endometrial cancer, and prostate cancer can be treated with hormonal therapy. Hormonal therapy is cost-effective for our patients.

Targeted Therapy

Targeted therapy is a cancer treatment in which medications target specific genes and proteins involved in cancer cell growth and survival. Targeted therapy can alter the tissue environment that aids cancer's growth and survival or target cancer-related cells such as blood vessel cells. Targeted therapy is an essential sort of cancer treatment, and as scientists discover more about specific changes in cancer cells, more targeted medications will be developed. However, only a few types of malignancies are currently treated exclusively with these medications.  People getting targeted therapy may also need surgery, chemotherapy, radiation therapy, or hormone therapy. 

Metronomic Chemotherapy

Metronomic chemotherapy is a contemporary approach to cancer treatment characterised by the continuous, low-dose administration of chemotherapy drugs at regular intervals. Unlike traditional chemotherapy, which employs higher doses with intermittent breaks, metronomic chemotherapy aims to exploit its anti-angiogenic properties—hindering the formation of new blood vessels that feed tumours. This method seeks to impede cancer growth with reduced toxicity compared to conventional treatments, making it a promising option for patients seeking a more tolerable therapeutic approach. With versatility across various cancer types and potential immunomodulatory effects, metronomic chemotherapy represents an evolving and accessible strategy in the ongoing quest for effective and patient-friendly cancer treatments.

Regional Chemotherapy

Regional chemotherapy is a targeted and localised approach to cancer treatment that involves delivering chemotherapy directly to a specific region of the body, often the site affected by the tumour. Unlike systemic chemotherapy, which circulates throughout the entire body, regional chemotherapy focuses on a defined area, allowing for higher drug concentrations at the tumour site while minimising exposure to healthy tissues. This approach may be employed through techniques such as intra-arterial infusion, intraperitoneal infusion, or isolated limb perfusion, depending on the cancer type and location. Regional chemotherapy aims to enhance treatment efficacy while reducing systemic side effects, offering a tailored and potentially more tolerable option for certain cancer patients.

All Solid and Hematological Malignancies

Solid tumours usually do not comprise cysts or liquid areas and are originally categorised as benign or malignant. Benign tumours are non-cancerous and do not spread to other parts of the body, while malignant tumours are cancerous and can spread to other parts of the body if left untreated. Cancers in the blood are also called haematological cancers. Cancers in the blood do not comprise tumours.

Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplant (HSCT) is a specialised procedure involving the transplantation of versatile stem cells, typically from the bone marrow, peripheral blood, or umbilical cord blood. Following conditioning therapy to eliminate diseased cells, healthy stem cells are infused, migrating to the bone marrow and restoring the production of normal blood cells. HSCT is a critical treatment for various hematologic malignancies and non-malignant conditions, offering patients a chance at recovery and improved quality of life by providing a new, healthy hematopoietic system. This procedure represents a powerful tool in hematology and oncology, contributing to the advancement of lifesaving therapies.